Sunday, November 1, 2026

HomeHealth NewsStudy reveals targeted therapy for aggressive liver cancer

Study reveals targeted therapy for aggressive liver cancer

- Advertisement -

Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated that a combination therapy using angiogenesis inhibition along with immune checkpoint inhibitors is a promising treatment approach for managing the aggressive HCC subtype. Credit: Institute of Science Tokyo
…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed